GlassScriptPhysician profile
Firas Ghanem
NPI 1124008529
$2,641.42
in general payments reported to CMS, 2019-2025
21 companies · $579 in 2025
The $579 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2021: $187 · 2022: $684 · 2023: $99.77 · 2024: $168 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $777.60 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $608.97 | 2019-2025 | Esprit, Dragonfly Opstar |
| Astrazeneca Pharmaceuticals LP | $400.70 | 2019-2023 | Brilinta |
| Abiomed | $370.57 | 2022-2025 | Impella |
| Heartflow, INC. | $337.44 | 2022-2025 | |
| Cardiovascular Systems INC. | $152.01 | 2019 | |
| Inari Medical, INC. | $132.17 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $119.49 | 2022 | |
| Boston Scientific Corporation | $98.42 | 2024-2025 | Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $71.04 | 2019-2022 | |
| Medtronic Vascular, INC. | $68.49 | 2019 | |
| Janssen Pharmaceuticals, INC | $65.06 | 2019 | |
| Lundbeck LLC | $38.86 | 2019 | |
| Amgen INC. | $29.31 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.60 | 2019 | |
| Novo Nordisk INC | $22.23 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $22.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.13 | 2019 | |
| Pfizer INC. | $16.85 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.98 | 2019 | |
| W. L. Gore & Associates, INC. | $14.64 | 2019 | |
| Gilead Sciences, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Firas Ghanem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.